PE Spronk

Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?

PE Spronk, E. J. Ter Borg, P. C. Limburg et al. · Clinical & Experimental Immunology · 1992 · 108 citations · Full text

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS

PE Spronk, Hendrika Bootsma, Gerda Horst et al. · Lara D. Veeken · 1996 · 68 citations · Full text

Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE)

PE Spronk, Gerda Horst, Bernardina T.F. van der Gun et al. · Clinical & Experimental Immunology · 1996 · 61 citations · Full text

Immunology, B Cell Activation, Pathology +16

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial

MM Van Eijk, Roes Kc, ML Honing et al. · Critical Care · 2011 · 42 citations · Full text

Ill Patients, Psychotropic Medication, Usual Care +16

Do Elevated Levels of Serum-Soluble Fas Contribute to the Persistence of Activated Lymphocytes in Systemic Lupus Erythematosus?

Marc Bijl, Th. van Lopik, P. C. Limburg et al. · Journal of Autoimmunity · 1998 · 36 citations

Inflammation, Serum-soluble Fas Contribute, Autoimmune Disease +12